Wells Fargo Maintains Overweight on Omnicell, Lowers Price Target to $50
Benzinga Newsdesk 3 months ago
NewsPrice TargetAnalyst Ratings
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Wells Fargo analyst Stan Berenshteyn maintains Omnicell (NASDAQ:OMCL) with a Overweight and lowers the price target from $55 to $50.
Wells Fargo analyst Stan Berenshteyn maintains Omnicell (NASDAQ:OMCL) with a Overweight and lowers the price target from $55 to $50.